Distinguishing awareness deficits after acquired brain injury: Validation of a clinical assessment tool in a Dutch sample.

Distinguishing awareness deficits after acquired brain injury: Validation of a clinical assessment tool in a Dutch sample. - Distinguishing awareness deficits

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43799

Enrollment

Registered

2013-05-13

Start date

2013-07-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

niet-aangeboren hersenletsel traumatic brain injury

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients will be male or female and will be 18 years or older. Patients will be eligible for inclusion in the study if they have had a traumatic brain injury; if they have moderate to severe brain injury; if they are at least 6 months post injury and maximally 5 years post injury; if they were discharged home after rehabilitation; if a significant other is willing to participate; and if informed consent is signed. Significant others (male or female) will be eligible for participation if they are 18 years or older.

Exclusion criteria

Exclusion criteria: Patients will be excluded from participation if they had a premorbid psychiatric disorder for which treatment was necessary; if no data of a post-injury MRI scan is available; if they do not want feedback of their memory and speed of processing test results; if they do not wish to be contacted in case severe abnormalities are found; if they are unable to complete the interview and assessment due to language and communication problems; and if it is indicated in the file that the patient does not want to participate in scientific research. Significant others will be excluded if they are unable to complete the interview and assessment due to language and communication problems.

Design outcomes

Primary

Measure	Time frame
Convergent validity: correlation between the CRS-ISA-DD and tools that measure similar constructs (Patient Competency Rating Scale, COPE Inventory and responses to Thematic Apperception Test pictures); inter-rater reliability: correlations between scores on the CRS-ISA-DD of two independent raters; internal consistency: Cronbach*s alpha of the CRS-ISA scale and the CRS-DD scale; feasibility: means and frequencies on a feasibility questionnaire.	—

Measure

Time frame

Convergent validity: correlation between the CRS-ISA-DD and tools that measure similar constructs (Patient Competency Rating Scale, COPE Inventory and responses to Thematic Apperception Test pictures); inter-rater reliability: correlations between scores on the CRS-ISA-DD of two independent raters; internal consistency: Cronbach*s alpha of the CRS-ISA scale and the CRS-DD scale; feasibility: means and frequencies on a feasibility questionnaire.

—

Secondary

Measure	Time frame
Correlations between impaired awareness of deficits (PCRS, COPE Inventory, Thematic Apperception Test, CRS-ISA-DD) and neurological data (MRI scan data, fingertapping, ZOO test, verbal fluency) and psychological data (Hospital Anxiety Depression Scale).	—

Countries

Netherlands

Outcome results